Cargando…

Metastatic Hepatocellular Carcinoma in a Patient with Crohn's Disease Treated with Azathioprine and Infliximab: A Case Report and Literature Review

Hepatocellular carcinoma most commonly occurs in patients with underlying liver disease or cirrhosis. We describe a case of hepatocellular carcinoma in a 34-year-old man with Crohn's disease treated with azathioprine and infliximab. The patient had no history of liver disease and a complete aut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fortinsky, Kyle J., Alali, Ali, Jeejeebhoy, Khursheed, Fischer, Sandra, Sherman, Morris, Fung, Scott
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283353/ https://www.ncbi.nlm.nih.gov/pubmed/25587469 http://dx.doi.org/10.1155/2014/340836

Ejemplares similares

Resected Hepatocellular Carcinoma in a Patient with Crohn's Disease on Azathioprine
por: Heron, Valérie, et al.
Publicado: (2016)

The Efficacy of Infliximab Monotherapy versus Infliximab-Azathioprine Sequential Treatment in Crohn's Disease: Experience from a Tertiary Medical Center in China
por: Zhang, Tianyu, et al.
Publicado: (2016)

Metastatic Crohn’s disease despite infliximab therapy
por: Campos, Sara, et al.
Publicado: (2017)

Infliximab to treat Crohn’s disease: an update
por: Cottone, M, et al.
Publicado: (2011)

Sweet Syndrome Associated With Crohn’s Disease Developed After a Combo Therapy With Infliximab and Azathioprine: A Case Report
por: Sotiropoulos, Christos, et al.
Publicado: (2021)

Azathioprine/infliximab/mesalazine: Coronavirus disease-19: case report
Publicado: (2020)

Recurrent Hepatocellular Carcinoma in Patient with Crohn's Disease: Incidental or Expected Outcome of Azathioprine?
por: Botros, Youssef, et al.
Publicado: (2015)

Thalidomide Combined With Azathioprine as Induction and Maintenance Therapy for Azathioprine-Refractory Crohn's Disease Patients
por: Li, Tong, et al.
Publicado: (2020)

Refractory Duodenal Crohn's Disease Successfully Treated with Infliximab
por: Kim, You Lim, et al.
Publicado: (2014)

Lymphomatoid granulomatosis associated with azathioprine therapy in Crohn disease
por: Connors, William, et al.
Publicado: (2014)

Redox imbalance in Crohn's disease patients is modulated by Azathioprine
por: Tavassolifar, Mohammad Javad, et al.
Publicado: (2021)

Chronic Genotype 3 Hepatitis E in Pregnant Woman Receiving Infliximab and Azathioprine
por: Charre, Caroline, et al.
Publicado: (2018)

Infliximab for medical induction of remission in Crohn's disease
por: Gordon, Morris, et al.
Publicado: (2023)

Infliximab in the treatment of Crohn’s disease
por: Poggioli, Gilberto, et al.
Publicado: (2007)

Recalcitrant plantar warts during azathioprine therapy for Crohn’s disease
por: Timmer, Margriet R., et al.
Publicado: (2013)

Pancreatitis associated with azathioprine and 6-mercaptopurine use in Crohn’s disease: a systematic review
por: Gordon, Morris, et al.
Publicado: (2020)

The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease
por: Vande Casteele, Niels, et al.
Publicado: (2015)

Crohn’s Disease Successfully Treated With Infliximab in a Patient Receiving Hemodialysis: Case Report and Review of the Literature
por: Chiba, Mitsuro, et al.
Publicado: (2014)

Crohn's Disease Associated with Sweet's Syndrome and Sjögren's Syndrome Treated with Infliximab
por: Foster, Erina N., et al.
Publicado: (2005)

Co-existence of relapsing polychondritis and Crohn disease treated successfully with infliximab
por: Jung, Hye-In, et al.
Publicado: (2020)

Demodicosis as an opportunistic infection in a patient with Crohn’s disease treated with infliximab
por: Niedźwiedź, Michał, et al.
Publicado: (2022)

A Case of Crohn's Disease with Improvement after Azathioprine-Induced Pancytopenia
por: Choi, Yong Sung, et al.
Publicado: (2011)

Pure red cell aplasia due to azathioprine therapy for Crohn's disease
por: Kamath, Nagesh, et al.
Publicado: (2016)

Increased Risk of Liver Cirrhosis during Azathioprine Therapy for Crohn's Disease
por: Roselli, Jenny, et al.
Publicado: (2020)

HLA variants associated with azathioprine‐induced pancreatitis in patients with Crohn’s disease
por: Ås, Joel, et al.
Publicado: (2022)

Isolated pulmonary cryptococcosis in a patient with Crohn's disease treated with infliximab: A case report and literature review
por: Hussein, Mousa, et al.
Publicado: (2021)

Serum Levels of Infliximab and Anti-Infliximab Antibodies in Brazilian Patients with Crohn's Disease
por: Gomes, Luis Eduardo Miani, et al.
Publicado: (2019)

A Case of Osteonecrosis of the Jaw in a Patient with Crohn’s Disease Treated with Infliximab
por: Favia, Gianfranco, et al.
Publicado: (2017)

Chronic Granulomatous Disease Mimicking Colonic Crohn’s Disease Successfully Treated with Infliximab
por: Peixoto, Armando, et al.
Publicado: (2017)

Acute submandibular sialadenitis in a patient with Crohn's disease being treated with infliximab()
por: Blasco Patiño, Felipe, et al.
Publicado: (2021)

Profile of infliximab in the treatment of pediatric Crohn’s disease
por: Kierkus, Jaroslaw, et al.
Publicado: (2015)

Myelolipoma After Infliximab Treatment for Crohn's Disease
por: Cesa, Kevin, et al.
Publicado: (2022)

Invasive pulmonary aspergillosis and pulmonary tuberculosis in a patient treated with infliximab for Crohn’s disease
por: Buonomo, Antonio Riccardo, et al.
Publicado: (2019)

Multiple liver abscesses in Crohn’s disease in infliximab therapy, successfully treated with antibiotic therapy
por: Otheo, Enrique, et al.
Publicado: (2019)

Body composition parameters correlate with the endoscopic severity in Crohn’s disease patients treated with infliximab
por: Tang, Wuli, et al.
Publicado: (2023)

Low-dose azathioprine is effective in maintaining remission among Chinese patients with Crohn’s disease
por: Wu, Jianghong, et al.
Publicado: (2013)

Pulmonary Mycobacterium avium Infection in a Patient with Crohn's Disease under Azathioprine Treatment
por: Hirano, Tomonori, et al.
Publicado: (2014)

Patients' Educational Program Could Improve Azathioprine Adherence in Crohn's Disease Maintenance Therapy
por: Wang, Lei, et al.
Publicado: (2020)

Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease
por: Buisson, Anthony, et al.
Publicado: (2021)

Non-cirrhotic portal hypertension related to azathioprine therapy in a patient with Crohn’s disease
por: Seo, Jong Won, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5rhv6e7ets34ljphb0s2r6ka89